Alterity Therapeutics (ATHE) announced that new presentations related to its Multiple System Atrophy program were delivered at the American ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) has announced promising new data from its Phase 2 trial of ATH434 in Multiple ...

Alterity Therapeutics (ASX:ATH), a biotechnology company focused on developing disease-modifying treatments for neurodegenerative conditions, presented new data from its Phase 2 ATH434 trial in ...

In other recent news, Alterity Therapeutics Limited has secured A$40 million in funding to advance the development of its lead drug candidate, ATH434, for Multiple System Atrophy (MSA). This funding ...

In other recent news, Alterity Therapeutics Limited has secured A$40 million in funding to advance the development of its lead drug candidate, ATH434, aimed at treating Multiple System Atrophy (MSA).

As part of its ongoing commitment to environmental sustainability, Mynco has planned several additional activities to support China's National Tree Planting Day 2025. The company is dedicated to ...

Arika Resources Limited (ASX: ARI) has announced significant high-grade gold intercepts from its maiden diamond drilling program at the Pennyweight Point Prospect within the Yundamindra Gold JV ...

Arika Resources (ASX: ARI) has announced multiple high-grade gold intercepts from its maiden diamond drilling program at the Pennyweight Point Prospect, part of the Yundamindra Gold JV Project in ...

As of 1:14:03 pm AEST. Market open.

At close: April 11 at 4:00:00 p.m. EDT ...